Welcome to LookChem.com Sign In|Join Free
  • or
2-Butenoic acid, 4-cyclohexyl-2-hydroxy-4-oxo-, ethyl ester, (2Z)- is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

849239-68-5

Post Buying Request

849239-68-5 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

849239-68-5 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 849239-68-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,4,9,2,3 and 9 respectively; the second part has 2 digits, 6 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 849239-68:
(8*8)+(7*4)+(6*9)+(5*2)+(4*3)+(3*9)+(2*6)+(1*8)=215
215 % 10 = 5
So 849239-68-5 is a valid CAS Registry Number.

849239-68-5Relevant academic research and scientific papers

Analogs of 4-hydroxyisoleucine and uses thereof

-

Page/Page column 44, (2008/06/13)

The invention relates to analogs of 4-hydroxyisoleucine, and to lactones, pharmaceutically acceptable salts, and prodrugs thereof, to processes for their preparation, and to pharmaceutical compositions comprising the same. The analogs of the invention stimulate both glucose uptake and insulin secretion, and may thus be useful for the prevention and treatment of disorders of carbohydrate or lipid metabolism, including diabetes mellitus (type 1 and type 2 diabetes), pre-diabetes, and Metabolic Syndrome.

Compounds and compositions for use in the prevention and treatment of obesity and related syndromes

-

Page/Page column 56, (2010/11/24)

The invention relates to 4-hydroxyisoleucine, isomers, analogs, lactones, salts, and prodrugs thereof, to processes for their preparation, and to pharmaceutical compositions comprising the same. More particularly, the invention relates to the use of those compounds in the prevention and treatment of obesity and related syndromes.

Cycloalkyl heterocycles for treating Hepatitis C virus

-

Page/Page column 32, (2010/02/11)

Compounds of Formula I are disclosed which inhibit hepatitis C NS5B RNA-dependent RNA polymerase and are useful for treating hepatitis C. Compositions and methods of using these compounds are also disclosed.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 849239-68-5